Maternal floor infarction of the placenta: Prenatal diagnosis and clinical significance

Obstetrics and Gynecology

Volumn 83, Issue 5, 1994, Pages 750-754

  Mandsager, Neil T ^a   Bendon, Robert ^a   Mostello, Dorothea ^a   Rosenn, Barak ^a   Miodovnik, Menachem ^a   Siddiqi, Tariq A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPLICATION; CONTROLLED STUDY; ETIOLOGY; FEMALE; HUMAN; INFARCTION; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK FACTOR; STILLBIRTH; ULTRASOUND;

ADULT; FEMALE; FETAL GROWTH RETARDATION; HUMAN; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INFARCTION; OLIGOHYDRAMNIOS; PLACENTA; PREGNANCY; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 0028282399     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Benirschke K, Kaufmann P. The pathology of the human placenta. 2nd ed. New York: Springer-Verlag, 1990:406-11.
2. Naeye RL. Disorders of the placenta, fetus, and neonate: Diagnosis and clinical significance. St. Louis: Mosbey-Year Book, 1992:149-54.
3. Andres RL, Kuyper W, Resnik R, Piacquadio KM, Benirschke K. The association of maternal floor infarction of the placenta with adverse perinatal outcome. Am J Obstet Gynecol 1990;163:935-8.
4. Clewell WH, Manchester DK. Recurrent maternal floor infarction: A preventable cause of fetal death. Am J Obstet Gynecol 1983; 147:346-7.
5. Naeye RL. Maternal floor infarction. Hum Pathol 1985;16:823-8.
6. Vernof KK, Benirschke K, Kephart GM, Wasmoen TL, Gleich GJ. Maternal floor infarction: Relationship to X cells, major basic protein, and adverse perinatal outcome. Am J Obstet Gynecol 1992;167:1355-63.
7. Benirschke K, Driscoll SG. Maternal floor infarction. In: Benirschke K, Driscoll SG, eds. Pathology of the human placenta. New York: Springer-Verlag, 1967:328-30.
8. Nickel RE. Maternal floor infarction: An unusual cause of intrauterine growth retardation. Am J Dis Child 1988;142:1270-1.
9. Fox H. Placental pathology, abnormal placentation, and clinical significance. In: Reece EA, Hobbins JC, Mahoney MJ, Petrie RH, eds. Medicine of the fetus and mother. Philadelphia: JB Lippin-cott, 1992:67-9.
10. Hadi HI, Treadwell EL. Lupus anticoagulant and anticardiolipin antibodies in pregnancy: A review. I. Immunochemistry and clinical implications. Obstet Gynecol Surv 1990;45:780-91.
11. Robinson L, Grau P, Crandall BF. Pregnancy outcomes after increasing maternal serum alpha-fetoprotein levels. Obstet Gynecol 1989;74:17-20.
12. Green JR. Placenta previa and abruptio placentae. In: Creasy RK, Resnik R, eds. Maternal-fetal medicine: Principles and practice. 3rd ed. Philadelphia: WB Saunders, 1994:618.
13. Sieracki JC, Panke TW, Horvat BL, Perrin EV, Nanda B. Chorio-angiomas. Obstet Gynecol 1975;46:155-9.
14. Hirati GI, Masaki DI, O’Toole M, Medearis AL, Platt LD. Color flow mapping and Doppler velocimetry in the diagnosis and management of a placental chorioangioma associated with non-immune fetal hydrops. Obstet Gynecol 1993;81:850-2.